These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 8133533)

  • 21. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
    Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P
    Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of Bcl-2 in node-negative breast cancer is associated with various prognostic factors, but does not predict response to one course of perioperative chemotherapy.
    van Slooten HJ; Clahsen PC; van Dierendonck JH; Duval C; Pallud C; Mandard AM; Delobelle-Deroide A; van de Velde CJ; van de Vijver MJ
    Br J Cancer; 1996 Jul; 74(1):78-85. PubMed ID: 8679463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.
    Linjawi A; Kontogiannea M; Halwani F; Edwardes M; Meterissian S
    J Am Coll Surg; 2004 Jan; 198(1):83-90. PubMed ID: 14698315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of Bcl-2, but not Bax, correlates with estrogen receptor status and tumor proliferation in invasive breast carcinoma.
    Yang Q; Sakurai T; Jing X; Utsunomiya H; Shan L; Nakamura Y; Nakamura M; Oura S; Suzuma T; Yoshimura G; Umemura T; Kokawa Y; Kakudo K
    Pathol Int; 1999 Sep; 49(9):775-80. PubMed ID: 10504548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bcl-2 and p53 expression in node-negative breast carcinoma: a study with long-term follow-up.
    Barbareschi M; Caffo O; Veronese S; Leek RD; Fina P; Fox S; Bonzanini M; Girlando S; Morelli L; Eccher C; Pezzella F; Doglioni C; Dalla Palma P; Harris A
    Hum Pathol; 1996 Nov; 27(11):1149-55. PubMed ID: 8912823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical expression of Bcl-2 protein in breast lesions: correlation with Bax, p53, Rb, C-erbB-2, EGFR and proliferation indices.
    Ioachim EE; Malamou-Mitsi V; Kamina SA; Goussia AC; Agnantis NJ
    Anticancer Res; 2000; 20(6B):4221-5. PubMed ID: 11205251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction.
    Ishida H; Irie K; Itoh T; Furukawa T; Tokunaga O
    Cancer; 1997 Sep; 80(6):1034-45. PubMed ID: 9305703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulators of apoptosis in human breast cancer.
    Eissa S; Labib R; Khalifa A; Swelam N; Khalil F; El-Shenawy AM
    Clin Biochem; 1999 Jul; 32(5):321-6. PubMed ID: 10480445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relevance of the expression of bcl-2 in combination with p53 as a prognostic factor in breast cancer.
    Jansen RL; Joosten-Achjanie SR; Volovics A; Arends JW; Hupperets PS; Hillen HF; Schouten HC
    Anticancer Res; 1998; 18(6A):4455-62. PubMed ID: 9891509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer.
    Jacobs TW; Prioleau JE; Stillman IE; Schnitt SJ
    J Natl Cancer Inst; 1996 Aug; 88(15):1054-9. PubMed ID: 8683636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of p53 and bcl-2 expression in patients treated with breast conservative therapy.
    Kim K; Chie EK; Han W; Noh DY; Park IA; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    J Korean Med Sci; 2010 Feb; 25(2):235-9. PubMed ID: 20119576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bcl-2 expression is associated with lymph node metastasis in human ductal breast carcinoma.
    Sierra A; Lloveras B; Castellsagué X; Moreno L; García-Ramirez M; Fabra A
    Int J Cancer; 1995 Jan; 60(1):54-60. PubMed ID: 7814152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer.
    Rhee J; Han SW; Oh DY; Kim JH; Im SA; Han W; Park IA; Noh DY; Bang YJ; Kim TY
    BMC Cancer; 2008 Oct; 8():307. PubMed ID: 18947390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of P53 expression and S-phase cell fraction in paraffin-embedded tissue by a double-labeling technique.
    Benini E; Silvestrini R; Daidone MG; Canova S
    J Histochem Cytochem; 1995 Oct; 43(10):999-1003. PubMed ID: 7560890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The p53 positive Bcl-2 negative phenotype is an independent marker of prognosis in breast cancer.
    Rolland P; Spendlove I; Madjd Z; Rakha EA; Patel P; Ellis IO; Durrant L
    Int J Cancer; 2007 Mar; 120(6):1311-7. PubMed ID: 17187363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunofluorometric study of Bcl-2 and Bax expression in clinical fresh tumor samples from breast cancer patients.
    Martínez-Arribas F; Núñez-Villar MJ; Lucas AR; Sánchez J; Tejerina A; Schneider J
    Anticancer Res; 2003; 23(1B):565-8. PubMed ID: 12680147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bcl-2 is a prognostic marker in breast cancer independently of the Nottingham Prognostic Index.
    Callagy GM; Pharoah PD; Pinder SE; Hsu FD; Nielsen TO; Ragaz J; Ellis IO; Huntsman D; Caldas C
    Clin Cancer Res; 2006 Apr; 12(8):2468-75. PubMed ID: 16638854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enzyme-linked immunoabsorbent assay-detected p53 protein accumulation: a prognostic factor in a large breast cancer cohort.
    Levesque MA; Yu H; Clark GM; Diamandis EP
    J Clin Oncol; 1998 Aug; 16(8):2641-50. PubMed ID: 9704714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of p53 and bcl-2 in correlation to clinicopathological parameters, hormone receptor status and DNA ploidy in breast cancers.
    Friedrich K; Dimmer V; Haroske G; Lossnitzer A; Kasper M; Theissig F; Kunze KD
    Pathol Res Pract; 1995 Nov; 191(11):1114-21. PubMed ID: 8822113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunofluorometrically determined p53 accumulation as a prognostic indicator in Italian breast cancer patients.
    Levesque MA; Katsaros D; Yu H; Giai M; Genta F; Roagna R; Ponzone R; Massobrio M; Sismondi P; Diamandis EP
    Int J Cancer; 1998 Apr; 79(2):147-52. PubMed ID: 9583729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.